Announcements Trials
Browse Landscape

Phase

Phase NA 1Phase 4 1Phase 3 1Phase 2 1

Status

Completed 99Recruiting 44Unknown 30Active not recruiting 16Terminated 6Not yet recruiting 6Withdrawn 5Enrolling by invitation 4

Sponsor Class

OTHER 3INDUSTRY 1

Study Type

Interventional 4

Sponsor

Cancer Type

Lymphoid 2CNS 1

Conditions

Neoplasms 73Breast Neoplasms 73Colorectal Neoplasms 39Prostatic Neoplasms 37Carcinoma, Non-Small-Cell Lung 27Lung Neoplasms 26Uterine Cervical Neoplasms 20Stomach Neoplasms 20Carcinoma, Hepatocellular 20Pancreatic Neoplasms 15Anxiety Disorders 15Leukemia, Myeloid, Acute 14Hematologic Neoplasms 13Colonic Neoplasms 13Urinary Bladder Neoplasms 12Lymphoma, Follicular 12Brain Neoplasms 12Precursor Cell Lymphoblastic Leukemia-Lymphoma 11Head and Neck Neoplasms 10Esophageal Neoplasms 10Diabetes Mellitus 10Sarcoma 9Ovarian Neoplasms 9Melanoma 9Liver Neoplasms 9Esophageal Squamous Cell Carcinoma 9Rectal Neoplasms 8Pulmonary Disease, Chronic Obstructive 8Epilepsy 8Disease 8

Interventions

7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Enrolling by invitation × Cognitive Dysfunction × Clear all
NCT06723015 2025-11-18

Tau PET Outcomes With Anti-amyloid Immunotherapies

Mayo Clinic

Phase 2 Enrolling by invitation
135 enrolled
Lymphoid

Alzheimer Disease, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

NCT02670161 2025-08-24

Quality Improvement and Practice Based Research in Neurology Using the EMR

Endeavor Health

Phase 4 Enrolling by invitation
3,300 enrolled
CNS

Brain Concussion, Brain Neoplasms, Epilepsy, Migraine Disorders, Multiple Sclerosis, Parkinson Disease, Restless Legs Syndrome, Stroke, Cognitive Dysfunction

NCT06950190 2025-08-12

(ECCPC)

Ellis Medicine

Phase 3 Enrolling by invitation
100 enrolled

Chemotherapy-Related Cognitive Impairment, Neurotoxicity Syndromes, Cognitive Dysfunction

NCT06245031 2024-05-07

Extension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)

Cognito Therapeutics, Inc.

Phase NA Enrolling by invitation
402 enrolled
Lymphoid

Alzheimer Disease, Dementia, Lymphoma, Follicular, Cognitive Dysfunction

Data powered by HemOnc (CC BY 4.0) Colophon âš¡